The results displayed that peripheral blood-derived Exos from T2D patients carry miR-135a-3p into HVSMCs, which activates the ErbB signaling pathway by inhibiting ATM, thereby enhancing the migration ability of HVSMCs. This evidence concerns the gene ATM and type 2 diabetes mellitus.